|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operations: | |||||
| Depreciation | |||||
| Stock-based compensation | |||||
| Accretion of discount on short-term investments | |||||
| Credit losses | |||||
| Amortization of deferred debt origination cost | |||||
| Amortization of final payment fees of old debt | |||||
| Amortization of right-of-use assets | |||||
| Amortization of deferred offering cost | |||||
| Change in fair value of derivative liabilities | |||||
| Other non-cash changes, net | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable and accrued expenses | |||||
| Operating lease liabilities | |||||
| Deferred revenue | |||||
| Income tax payable | |||||
| Tenant improvement allowance | |||||
| Net cash used in operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Purchases of equipment | |||||
| Investment in China Joint Venture | |||||
| Purchases of software development | |||||
| Maturities of short-term investments | |||||
| Purchases of short-term investments | |||||
| Net cash provided by (used in) investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Proceeds from issuances under equity line of credit net of costs | |||||
| Deferred debt origination costs | |||||
| Net settlement of vested restricted stock units to fund related employee statutory tax withholding | |||||
| Proceeds from sale of pre-funded warrants, net of offering costs | |||||
| Proceeds from sale of common stock and pre-funded warrants, net of offering costs | |||||
| Repayment of debt | |||||
| Final payment fees of old debt | |||||
| Payment of debt issuance costs | |||||
| Proceeds from issuance of debt, revolving credit line | |||||
| Proceeds from issuance of debt, term loan | |||||
| Proceeds from issuance of debt, Avenue Capital | |||||
| Net cash provided by financing activities | |||||
| Effect of foreign exchange rate changes on cash | |||||
| Net increase in cash and cash equivalents | |||||
| Cash, cash equivalents and restricted cash beginning of year | |||||
| Cash, cash equivalents and restricted cash end of year | |||||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | |||||
| Cash paid during the period for income taxes | |||||
| Cash paid during the period for interest | |||||
| Non-cash financing and investing activities | |||||
| Issuance of 50,000 shares of common stock as commitment fee for future financing | |||||
| Right of use assets obtained in exchange for lease obligations | |||||
| Deferred offering costs incurred in a prior period to additional paid in capital | |||||
| Unrealized (gain) loss from mark to market on short-term investments | |||||
Loading...